This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
ADSTILADRIN
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
ECLIPSE
ESCAPE
FORT
NRG-GU 0101
Masofaniten (EPI-7386)
METANOVA
RTIRE
SHORTER
Right Side
PCCTC
DORA
IRONMAN
PROMISE
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SESAUA 2024
Southern CA GU Cancer Research Forum 2024
AUA Urology Advocacy Summit 2024
ASCO GU 2024
2024 UCSF-UCLA PSMA Conference
SUO 2023
All Conferences
View All
PCF
UroToday Home
Newsletter Archive
Prostate Cancer Weekly
Go
Reset
Send Date
Subject
Created Date
ID
Asc
Desc
PARP Inhibitors: Targeting DNA Repair Pathways
Sent on 28 March 2024
Receive via e-mail
UroAlerts - Prostate Cancer Weekly
Sent on 26 March 2024
Receive via e-mail
Southeastern Section of the AUA Highlights in Prostate Cancer
Sent on 26 March 2024
Receive via e-mail
Staging and Treatment Planning with PSMA Molecular Imaging
Sent on 22 March 2024
Receive via e-mail
UroAlerts - Prostate Cancer Weekly
Sent on 19 March 2024
Receive via e-mail
Research and Innovation Leading to New Targets for Theranostics in Prostate Cancer
Sent on 19 March 2024
Receive via e-mail
Collaborative Workflow Sharing Among Clinicians for Patients with Prostate Cancer
Sent on 14 March 2024
Receive via e-mail
UroAlerts - Prostate Cancer Weekly
Sent on 12 March 2024
Receive via e-mail
Clinical Trials Enhancing Clinical Choices for PSMA Imaging and Therapy Selection
Sent on 12 March 2024
Receive via e-mail
International Women's Day 2024: Celebrating the Diverse Contributions of Women in Science
Sent on 08 March 2024
Receive via e-mail
UroAlerts - Prostate Cancer Weekly
Sent on 05 March 2024
Receive via e-mail
Collaboration in Managing mCRPC Patients Including Triplet Therapy Integration
Sent on 05 March 2024
Receive via e-mail
Prostate Cancer Foundation's Guidelines for Black Men in the United States
Sent on 02 March 2024
Receive via e-mail
Transforming Healthcare Policy: Challenges, Strategies, and Advocacy Priorities
Sent on 01 March 2024
Receive via e-mail
The Heterogeneity of Prostate Cancer Prompts a Shift Towards a Targeted Treatment Approach
Sent on 29 February 2024
Receive via e-mail
Advances in PSMA Theranostics: From Diagnosis to Treatment in Prostate Cancer
Sent on 28 February 2024
Receive via e-mail
UroAlerts - Prostate Cancer Weekly
Sent on 27 February 2024
Receive via e-mail
Design, Access and Consensus Criteria in GU Clinical Trials
Sent on 24 February 2024
Receive via e-mail
Managing Nonmetastatic CRPC: Imaging, Treatment Options, and Provider Collaboration
Sent on 23 February 2024
Receive via e-mail
UroAlerts - Prostate Cancer Weekly
Sent on 20 February 2024
Receive via e-mail
Challenging Androgen Resistance in Prostate Cancer with Novel Approaches
Sent on 16 February 2024
Receive via e-mail
Learning from the Experts: Exploring New Pathways Beyond Androgen Blockade for Treating mCRPC and mHSPC
Sent on 15 February 2024
Receive via e-mail
Understanding the Biological Basis of mCRPC Leads to Novel Approaches to Management
Sent on 14 February 2024
Receive via e-mail
UroAlerts - Prostate Cancer Weekly
Sent on 13 February 2024
Receive via e-mail
PSMA PET Imaging for Staging and Patient Selection for PSMA Radioligand Therapy
Sent on 13 February 2024
Receive via e-mail
Experts Gather to Present Updates on Theranostics at the Inaugural UCLA/UCSF PSMA PET Conference
Sent on 12 February 2024
Receive via e-mail
A Clinical Team Approach: Optimizing Treatment in Men with mHSPC
Sent on 10 February 2024
Receive via e-mail
Advanced Imaging for Diagnosis and Impact to Management Considerations for nmCRPC
Sent on 09 February 2024
Receive via e-mail
Novel Treatment Pathways Providing Future Management Options for Advanced Prostate Cancer
Sent on 07 February 2024
Receive via e-mail
UroAlerts - Prostate Cancer Weekly
Sent on 06 February 2024
Receive via e-mail
Sequencing Strategies in Metastatic Castration-Resistant Prostate Cancer
Sent on 05 February 2024
Receive via e-mail
Clinical Management for Patients with Metastatic Hormone-Sensitive Disease with Intensification of Therapy and Collaboration
Sent on 02 February 2024
Receive via e-mail
Key Takeaways from the Inaugural UCLA/UCSF PSMA PET & RLT Conference
Sent on 01 February 2024
Receive via e-mail
Recap of GU Oncology Highlights, Prostate, Bladder, and Renal: ASCO GU 2024
Sent on 31 January 2024
Receive via e-mail
UroAlerts - Prostate Cancer Weekly
Sent on 30 January 2024
Receive via e-mail
Imaging, Therapeutics and Collaboration in Care for Prostate Cancer Patients: ASCO GU 2024
Sent on 30 January 2024
Receive via e-mail
Emerging Evidence in Localized and Recurrent Prostate Cancer: Genomic Insights, Novel Therapeutics, and Enhanced Detection Strategies ASCO GU 2024
Sent on 26 January 2024
Receive via e-mail
Highlights from ASCO GU 2024 on Prostate Cancer Treatment Modalities
Sent on 25 January 2024
Receive via e-mail
Breakthrough Trial Highlights in Prostate Cancer from ASCO GU Day One
Sent on 25 January 2024
Receive via e-mail
Biomarkers Guiding Strategies for a Precision Approach for Patients with Metastatic Castration-Resistant Prostate Cancer
Sent on 24 January 2024
Receive via e-mail
UroAlerts - Prostate Cancer Weekly
Sent on 23 January 2024
Receive via e-mail
ProtectT Trial 15-Year Data: A Journal Club for Patients with Prostate Cancer Highlights Data with Expert Clinicians
Sent on 22 January 2024
Receive via e-mail
The Inaugural "PSMA PET and RLT: Present and Future" Conference Highlights
Sent on 20 January 2024
Receive via e-mail
Join UroToday at ASCO GU 2024 for Conference Coverage Written by Clinicians for Clinicians
Sent on 18 January 2024
Receive via e-mail
Operationalizing Radioligand Therapy in a Multidisciplinary Advanced Prostate Cancer Urology Clinic
Sent on 17 January 2024
Receive via e-mail
UroAlerts - Prostate Cancer Weekly
Sent on 16 January 2024
Receive via e-mail
Starts Thursday: A Collaboration of Excellence with UCSF & UCLA - The 2024 PSMA Conference
Sent on 15 January 2024
Receive via e-mail
The Impact of Regional and Racial Disparities on Prostate Cancer
Sent on 12 January 2024
Receive via e-mail
The Role for Circulating Tumor DNA (ctDNA) in Treatment Strategy for Prostate Cancer
Sent on 11 January 2024
Receive via e-mail
The Underutilization of Treatments and Testing in Advanced Prostate Cancer
Sent on 10 January 2024
Receive via e-mail
Page
of 37
Display #
5
10
15
20
25
30
50
100
Results 1 - 50 out of 1813
Send the selected Newsletters to...
Name
E-mail
Send
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free